Advanced Therapies’ Post

Transcript

Hi there, I'm Kevin Holden, I'm VP of Science at Synthego. We are a genome engineering company that is focused on providing reagents and support for people working with CRISPR based cell and gene therapies. So specifically we provide the guide RNA from both the research scale all the way to a clinical grade GMP scale. So we're very excited to be here at Advanced Therapies. We'd love for people to come and talk to us about how we can support their synergy therapy development. From research in all the way into the clinic, we also provide regulatory support for our clients as well. And we enjoy being at conferences like advanced therapies because we get to interact directly with scientists who are developing cell and gene advanced therapies and also find new customers as well. So thanks for having us.